Allozymes

Allozymes is a biotechnology company based in Singapore, founded in 2019.

The company specializes in enzyme discovery and engineering, utilizing its proprietary ZymeLeapTM platform, which combines ultra-high-throughput microfluidics and machine learning. This innovative approach allows Allozymes to screen up to 20 million enzyme variants daily, significantly accelerating the development of custom-designed enzymes for various industrial applications. Allozymes offers a range of B2B services, including enzyme engineering, access to a comprehensive enzyme database, and flexible licensing for proprietary biosolutions. Their solutions cater to diverse industries such as pharmaceuticals, food and nutrition, chemicals, personal care, and bioremediation. The company aims to provide sustainable alternatives to traditional manufacturing processes, contributing to climate change mitigation and waste reduction.